Keyword: immunotherapy

News

Korean Drug Specialists Collaborate on Cancer Therapy

23.11.2015 - Singapore-based biotechnology firm Aslan Pharmaceuticals, which specializes in immunotherapy and targeted agents for cancer forms prevalent in Asia, has agreed to cooperate with...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

News

Bristol-Myers to Buy Fibrosis Drug and its Developer

03.09.2015 - Bristol-Myers Squibb (BMS) will pay as much as $1.25 billion for the worldwide rights to a developing fibrosis drug as part of a deal that also gives it the right to buy the...

News

Mallinckrodt to Buy Immunotherapy Firm Therakos

13.08.2015 - Irish drugmaker Mallinckrodt said it plans to acquire US immunotherapy company Therakos for $1.33 billion from American private equity investor Gores Group. The deal is planned to...

News

Novartis Boosts Cancer Immunotherapy Research Efforts

31.03.2015 - Novartis is accelerating its efforts in the field of cancer immunotherapy with the launch of a dedicated research group and an alliance with US-based Aduro Biotech. The multi-year...

News

Anergis Expands Management Team

15.02.2013 - Anergis, a company developing breakthrough allergy vaccines for fast and safe allergen-specific immunotherapy, today announced the expansion of its management team. With the...